Literature DB >> 6823383

Hysteroscopic management of intrauterine lesions and intractable uterine bleeding.

A DeCherney, M L Polan.   

Abstract

Müllerian fusion defects, submucous myomas, and intractable uterine bleeding have been managed traditionally by major surgical intervention. However, the cystoscope-resectoscope provides the operative versatility allowing transvaginal surgical management of these situations. Forty women underwent hysteroscopy and treatment with the cystoscope-resectoscope at the Yale-New Haven Hospital. Those patients treated for septate müllerian defects also underwent concomitant laparoscopy. Therapeutic surgical use of the cystoscope-resectoscope resulted in no immediate or long-term complications. Of 11 patients with uterine anomalies treated in this fashion, 9 carried to term without difficulty. Fourteen women with space-occupying intrauterine lesions were treated and resumed normal cyclical menses for a minimum of 1 year. In all 11 patients with intractable uterine bleeding hemorrhage was controlled immediately and 6 women remained amenorrheic for a sustained period. The use of the cystoscope-resectoscope for the management of these entities provides several advantages: 1) A transcervical approach obviates the necessity for abdominal surgery, and 2) the instrument is rapidly and easily accessible to the practicing gynecologist.

Entities:  

Mesh:

Year:  1983        PMID: 6823383

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

Review 1.  Management of menorrhagia.

Authors:  A L Magos
Journal:  BMJ       Date:  1990-06-16

2.  Transcervical resection of endometrium in women with menorrhagia.

Authors:  A L Magos; R Baumann; A C Turnbull
Journal:  BMJ       Date:  1989-05-06

3.  Hysterectomy-current methods and alternatives for benign indications.

Authors:  Michail S Papadopoulos; Athanasios C Tolikas; Dimosthenis E Miliaras
Journal:  Obstet Gynecol Int       Date:  2010-07-28

4.  Patient satisfaction following transcervical resection of the endometrium.

Authors:  F McAuliffe; J English; W Prendiville
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

Review 5.  Anaesthetic implications of 32% Dextran-70 (Hyskon) during hysteroscopy: hysteroscopy syndrome.

Authors:  D Mangar
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

6.  Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding.

Authors:  S B Pinion; D E Parkin; D R Abramovich; A Naji; D A Alexander; I T Russell; H C Kitchener
Journal:  BMJ       Date:  1994-10-15

7.  Hysteroscopic endometrial destruction, optimum method for preoperative endometrial preparation: a prospective, randomized, multicenter evaluation.

Authors:  O Shawki; A Peters; S Abraham-Hebert
Journal:  JSLS       Date:  2002 Jan-Mar       Impact factor: 2.172

8.  Hysteroscopic endomyometrial resection.

Authors:  M Wortman; A Daggett
Journal:  JSLS       Date:  2000 Jul-Sep       Impact factor: 2.172

9.  Counselling patients with uterine fibroids: a review of the management and complications.

Authors:  Donnette Simms-Stewart; Horace Fletcher
Journal:  Obstet Gynecol Int       Date:  2012-01-09

10.  Hysteroscopic myomectomy: our experience and review.

Authors:  J L Muñoz; J S Jiménez; C Hernández; G Vaquero; C Pérez Sagaseta; R Noguero; P Miranda; J M Hernández; P De la Fuente
Journal:  JSLS       Date:  2003 Jan-Mar       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.